1. Novartis AG
2. Merck KGaA
3. Gilead Sciences Inc.
4. TCR2 Therapeutics Inc
5. Bluebird Bio Inc.
6. Sorrento Therapeutics
7. Fate Therapeutics Inc.
8. Pfizer Inc.
9. Amgen Inc
10. Celgene Corporation
Published | Pages | Publisher | Report code |
---|---|---|---|
Apr 2024 | 183 | TechSci Research | ASDR-663209 |
1. Novartis AG
2. Merck KGaA
3. Gilead Sciences Inc.
4. TCR2 Therapeutics Inc
5. Bluebird Bio Inc.
6. Sorrento Therapeutics
7. Fate Therapeutics Inc.
8. Pfizer Inc.
9. Amgen Inc
10. Celgene Corporation